-
Swede goes on trial for pressuring wife to sell sex
-
US inflation surges 3.3% as Iran war impact bites
-
Vance warns Iran not to 'play' US at talks in Pakistan
-
Fernandez remains out despite apology: Chelsea boss Rosenior
-
Dortmund defender Schlotterbeck extends contract until 2031
-
De Zerbi vows to save troubled Spurs from relegation
-
Antwerp port reopens to North Sea shipping after oil spill
-
Stocks mixed, oil steadies on guarded optimism for Iran ceasefire
-
Sinner eases into Monte Carlo semi-finals
-
France's Macron talks war, peace and basketball with Pope Leo
-
Fernandez apologised over comments about his future: Chelsea's Rosenior
-
Coach Spalletti signs new Juve deal until 2028
-
AI chatbots offer children harm as if it were help, says activist
-
'Grumpy' Guardiola wants Silva to stay at Man City for life
-
Zverev beats Fonseca to reach Monte Carlo semi-finals
-
Scheffler, Rose to chase McIlroy with early Masters starts
-
Celine Dion's Paris concerts promise to spin the money on and on
-
Stocks climb, oil steadies on guarded optimism over Iran war ceasefire
-
Irish govt to meet farmers, hauliers over fuel cost fears
-
Injured Bayern starlet Karl to miss Real return leg
-
US-Iran talks in Pakistan uncertain as sides trade accusations
-
Oil spill snarls shipping traffic in Antwerp port
-
Giving birth in a shelter in Israel
-
Five things to know about the planned Iran-US talks in Islamabad
-
Slot feels 'complete support' from Liverpool chiefs despite slump
-
Kyiv books tentative diplomatic coup with Iran war forays
-
Teenager shines as Britain seize control of BJK Cup tie with Australia
-
Chinese, Taiwanese will unite, Xi tells Taiwan opposition leader
-
Sleepy seal diverts traffic in Australian seaside town
-
Artemis astronauts to shed light on space health risks
-
Pakistan prepares to host US-Iran talks, as Lebanon fighting continues
-
Vaccine gaps fuel Bangladesh's deadly measles crisis
-
Fish furore fuels fierce election in India's West Bengal
-
Coachella kicks off with headliners Sabrina Carpenter, Bieber and Karol G
-
Myanmar junta chief sworn in as president
-
Exiled cartoonists give voice to Iran's silenced millions
-
In Pakistan's mediation to end Mideast war, China may hold the key
-
Knicks stay in hunt with late win over rival Celtics
-
'Sartorial diplomacy' on show in expo of late UK queen's fashion
-
Former Japan and AC Milan star Honda laces up boots again at 39
-
Stocks rally on optimism over Iran war ceasefire, oil extends gains
-
Lego-style memes troll Trump after fragile US-Iran truce
-
Chinese slimmers trade lost fat for beef
-
Jackson biopic shows franchise thriving despite abuse claims
-
New Jersey city spurns data center as defiance spreads
-
US box office looking good as cinema owners gather: industry chief
-
Firm Masters greens make life hard on golf's finest
-
BIO-key International, 20/20 Biolabs, Society Pass, and Soligenix Interviews to Air on the RedChip Small Stocks, Big Money(TM) Show on Bloomberg TV
-
Designed for the Desk, Built for the Day: The Epomaker TH108 V2 Pro
-
Releaf Crosses 25,000 Patients With Record Revenue
Wellgistics Health (NASDAQ: WGRX) Launches XRP Payment Program for Independent Pharmacies
TAMPA, FLORIDA / ACCESS Newswire / August 13, 2025 / Wellgistics Health, Inc. (NASDAQ:WGRX) ("Wellgistics Health" or the "Company"), a leader in next-generation pharmaceutical distribution, digital prescription routing, and AI-powered hub fulfillment, today announced the launch of its Ripple Labs-powered XRP Implementation Program, giving independent pharmacies access to blockchain-based payments in the prescription drug space for the first time. The program enables pharmacies to pay for products and move funds instantly, more cost-effectively, and with full transparency-eliminating delays, high fees, and reliance on traditional banking and credit card networks. Wellgistics Health is among the first healthcare companies to implement an XRP-based payment solution at scale.
The program operates in partnership with RxERP, a serialized pharmaceutical eCommerce and ERP (Enterprise Resource Planning) system that manages onboarding, transactions, and reporting for participating pharmacies. With Wellgistics already serving more than 6,500 independent pharmacies and over 200 manufacturers nationwide, the Company is well-positioned to accelerate adoption rapidly and at scale.
Pharmacies can now enroll in the beta program at:
https://wellgisticshealth.com/xrp-in-healthcare/
How Pharmacies Benefit from Using XRP
Instant Settlement - Payments settle in seconds, not days
Lower Fees - Avoid credit card and bank transaction costs
24/7 Availability - No banking delays, even on weekends and holidays
Improved Cash Flow - Faster access to working capital and inventory restock
Real-Time Tracking - View and confirm payments instantly
No Intermediaries - Direct transactions between pharmacy and distributor
"We've been impressed with the response so far," said Brian Norton, CEO of Wellgistics Health. "Independent pharmacy owners are far more forward-thinking than many realize. They see the power of blockchain and understand how transformative this will be as it scales across the industry. Our mission is to give pharmacies greater control, speed, and transparency in their financial operations."
Technical Innovation and Blockchain Integration
The XRP Payment Program harnesses the speed, scalability, and low-cost infrastructure of the XRP Ledger to meet the unique demands of the pharmaceutical supply chain. Integrated with RxERP, the platform delivers real-time, encrypted, and fully compliant payment processing tailored for independent pharmacies, wholesalers and in the near future, manufacturers.
Pharmacies and investors can learn more by downloading the Wellgistics Health XRP E-Book:
https://wellgisticshealth.com/xrp-in-healthcare/
Regulatory Compliance and Security
The XRP Payment Program has been developed to meet or exceed healthcare and financial regulatory standards, including HIPAA and anti-money laundering (AML) requirements. The system provides secure, traceable transactions while safeguarding sensitive data and maintaining privacy at every stage.
Next Phase: Manufacturer Onboarding and Direct-to-Patient (DTP) Programs
Following the pharmacy rollout, Wellgistics Health will begin onboarding pharmaceutical manufacturers to the XRP platform-expanding capabilities for direct, on-chain transactions. The Company also plans to launch manufacturer-powered Direct-to-Patient (DTP) programs, allowing manufacturers to ship medications directly to patients' homes in collaboration with their community pharmacy and prescribing physicians to ensure clinical continuity and compliance.
"Pharmacies deserve a payment system as fast and responsive as the care they provide," said Tony Madsen, COO of Wellgistics Health. "While this first phase focuses on helping pharmacies pay for products more efficiently, it's just the start. Our vision is to make every aspect of pharmacy payments faster, clearer, and completely frictionless."
About Wellgistics Health
Wellgistics Health (NASDAQ: WGRX) delivers medications from manufacturer to patient-faster, smarter, and more affordably. Its integrated platform connects 6,500+ independent pharmacies and 200+ U.S. manufacturers, providing wholesale distribution, digital prescription routing, and AI-powered hub services such as eligibility, adherence, onboarding, prior authorization, and cash-pay fulfillment. As a PBM-agnostic alternative, Wellgistics Health offers compliant, end-to-end solutions that restore access, transparency, and trust in U.S. healthcare.
About RxERP
RxERP is the only serialized pharmaceutical ERP system designed specifically for independent pharmacies, wholesalers, and manufacturers. It delivers real-time financial, operational, and compliance tools-integrating blockchain, AI, and serialized inventory management to streamline operations and modernize the supply chain. RxERP is the platform partner managing the XRP Implementation Program with Wellgistics Health.
Forward-Looking Statements
This press release may contain forward-looking statements regarding Wellgistics Health's plans, strategies, future operations, and expected performance. These statements are based on current expectations and involve risks and uncertainties that may cause actual results to differ materially. Factors that could affect these results include, but are not limited to, market conditions and risks detailed in filings with the SEC. Investors are cautioned not to place undue reliance on forward-looking statements. Additional information is available at www.sec.gov.
Media Contact: [email protected]
Investor Relations: [email protected]
Investor Relations Contact:
Skyline Corporate Communications Group, LLC
Scott Powell, President
1177 Avenue of the Americas, 5th Floor
New York, NY 10036
Office: (646) 893-5835
Email: [email protected]
SOURCE: Wellgistics Health, Inc.
View the original press release on ACCESS Newswire
G.P.Martin--AT